RUXOLITINIB

35732 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking RUXOLITINIB:

# Side effect Count
0 OFF LABEL USE 5738
1 DEATH 3605
2 FATIGUE 3337
3 HAEMOGLOBIN DECREASED 1961
4 ANAEMIA 1801
5 PLATELET COUNT DECREASED 1747
6 DIZZINESS 1620
7 DIARRHOEA 1535
8 HEADACHE 1494
9 PRODUCT DOSE OMISSION 1429
See all common reactions for RUXOLITINIB

RUXOLITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD ERYTHROPOIETIN ABNORMAL 35 0.6731
1 AQUAGENIC PRURITUS 28 0.5283
2 HAEMATOCRIT ABNORMAL 245 0.2849
3 DISEASE RISK FACTOR 36 0.2628
4 MYELOFIBROSIS 466 0.2240
5 BLAST CELLS PRESENT 65 0.1831
6 BLOOD LACTATE DEHYDROGENASE ABNORMAL 77 0.1689
7 MYELOPROLIFERATIVE NEOPLASM 51 0.1474
8 HAEMATOCRIT INCREASED 208 0.1425
9 PRIMARY MYELOFIBROSIS 33 0.1369
See all enriched reactions for RUXOLITINIB